What is LOPJLB’s current signal on CASI?

LOPJLB’s latest quantitative signal on CASI Pharmaceuticals, Inc. (CASI) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is CASI in?

CASI Pharmaceuticals, Inc. (CASI) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does CASI Pharmaceuticals, Inc. (CASI) do?

CASI Pharmaceuticals, Inc. is a biopharmaceutical firm focused on the development and market introduction of medical treatments and drugs across China, the United States, and globally. Its marketed product, EVOMELA, is an intravenous formulation of melphalan, utilized for conditioning prior to stem cell transplantation and as a palliative option for patients suffering from multiple myeloma. The…

Where is CASI Pharmaceuticals, Inc. based / listed?

CASI Pharmaceuticals, Inc. is based in CN, listed on NASDAQ.

CASI Pharmaceuticals, Inc. (CASI)

Healthcare · Biotechnology · NASDAQ · CN

$0.15+7.14%Close

SELLCRISIS · day 3

[SCORES & PROFILE]

FUND: 0
VALUE: 9
GROWTH: 24
GARP: 2
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC110.6%

REV YoY-

ROE184.3%

EPS YoY-

ROA-143.1%

GROSS

-239

NET

-260

[VALUATION]

P/E TTM-0.07

P/E FWD-

SECTOR PE22.62

INDUSTRY PE17.13

P/B-0.08

P/FCF-

EV/EBITDA-0.54

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO0.30

ND/EBITDA-

BETA0.89

CASI Pharmaceuticals, Inc. (CASI)

Key stats

Sector peers

Prediction markets

FUNDAMENTALS

Company news